INTEGRA Biosciences has announced a competitive grant programme offering laboratories the opportunity to win $10,000 worth of pipetting and automation equipment to address operational challenges and enhance experimental efficiency.
Advanced Chemistry Development (ACD/Labs) and materials science company Covestro have unveiled a collaborative project integrating artificial intelligence into solvent selection processes for pharmaceutical and chemical research. The partnership, announced at the PhysChem Forum 2025 in Basel, Switzerland, combines computational chemistry expertise with software development to address long-standing inefficiencies in laboratory workflows.
Researchers at the University of Connecticut have developed CARRD, a novel RNA detection method that operates at room temperature without pre-amplification, achieving attomolar sensitivity for viral diagnostics. The technique detected HIV and hepatitis C virus RNA at concentrations 10,000 times lower than standard CRISPR tests, potentially transforming point-of-care diagnostics in resource-limited settings.
Open-science publisher Frontiers has launched FAIR² Data Management, an integrated platform designed to address the significant challenge of scientific data loss and underutilisation. The service combines artificial intelligence with established data management protocols to streamline how research data is stored, shared, and reused across scientific disciplines.
Scientists at the University of Cambridge have created three-dimensional embryo-like structures from human stem cells that spontaneously produce blood cells, offering a new window into early human development and a potential source of cells for transplantation. The structures, called ‘hematoids’, develop beating heart cells and blood stem cells without requiring the complex cocktails of growth […]
HemostOD, a Swiss preclinical-stage company developing ex vivo manufactured universal human blood platelets, has closed a CHF 4.3 million seed extension financing round to advance pre-IND development and establish commercial-scale production capabilities. The funding round was co-led by Polytech Ventures and Orenok Holdings, with participation from the Lichtsteiner Foundation and private investors.
San Diego biotech company Replicate Bioscience has entered into a multi-year research collaboration with pharmaceutical giant Novo Nordisk to develop self-replicating RNA (srRNA) therapeutics targeting obesity, type 2 diabetes, and other cardiometabolic conditions. The partnership combines Replicate’s proprietary srRNA platform technology with Novo Nordisk’s expertise in metabolic disease to create a new class of therapeutic […]
Integrated DNA Technologies (IDT) has announced a strategic partnership with Hamilton Company to develop automated comprehensive genomic profiling workflows for cancer research and other genomic applications. The collaboration will integrate IDT’s customisable NGS research components with Hamilton’s precision liquid handling platforms.
Revvity has announced a comprehensive initiative to expand early detection capabilities for type 1 diabetes, combining in vitro diagnostic assay development with laboratory testing services in collaboration with Sanofi. The programme centres on advancing the company’s existing research-use autoantibody testing platform towards regulatory approval and broader clinical implementation.
Bio-Rad Laboratories has secured exclusive European distribution rights for Gencurix’s CE-IVD Droplex digital PCR oncology testing kits, marking a significant expansion of the companies’ existing collaboration in molecular diagnostics.
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.